← Leaderboards
Natalie Prigozhina
Origami Therapeutics, Inc.
$304,998
Attributed
$609,996
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $502.9K · FY2023–24$1M$750K$500K$250K$0
'23
'24
Funding mix
By agency
NIH$609,996 · 1
By mechanism
R43$609,996 · 1
Top collaborators
- Beth J Hoffman2 shared
Most similar at Origami Therapeutics, Inc.
Same institution · by research overlap
- Beth J Hoffman$804,986
Others in their field
Other Rising Stars on “Absorption”
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Alexander Kolykhalov · Emory University$8,116,465
- Anil Gupta · Scripps Research Institute, The$7,340,144
- Debra Burnin · Sri International$7,194,143
- David Burkhart · Inimmune Corporation$5,907,864
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$5,835,304
Research focus
AbsorptionAdme StudyAnalogAnimal ModelAreaAspiration PneumoniaAtrophicAutophagocytosisAutosomeBinding ProteinsBiological AvailabilityBloodBlood TestsBrainCag RepeatCell DeathCell Differentiation ProcessCell DivisionCell PhysiologyCellsCerebral CortexCerebrospinal FluidClinical TranslationAbcb1 Gene
Grant awards (2)
Characterization of small molecules that lower mutant huntingtin protein as potential therapeutics for Huntingtonâs disease$107,065
R43 · FY2024 · NS
Characterization of small molecules that lower mutant huntingtin protein as potential therapeutics for Huntingtonâs disease$502,931
R43 · FY2023 · NS